Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
To examine the effects of 12 weeks of treatment with the DPP-4 inhibitor, sitagliptin, on gastrointestinal hormone responses to a standardized mixed meal and beta cell secretory capacity, measured as glucose and non-glucose induced insulin secretion during a hyperglycaemic clamp, in patients with type 2 diabetes.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Diabetes, Obesity and Metabolism |
Vol/bind | 12 |
Udgave nummer | 4 |
Sider (fra-til) | 323-33 |
Antal sider | 11 |
ISSN | 1462-8902 |
DOI | |
Status | Udgivet - 1 apr. 2010 |
ID: 33939951